000181943 001__ 181943
000181943 005__ 20240229145702.0
000181943 0247_ $$2doi$$a10.1007/s00105-022-05054-w
000181943 0247_ $$2pmid$$apmid:36169683
000181943 037__ $$aDKFZ-2022-02313
000181943 041__ $$aGerman
000181943 082__ $$a610
000181943 1001_ $$aSchneider, Hanna$$b0
000181943 245__ $$aAssessment of an e-learning platform for dermatosurgery.[Beurteilung einer E‑Learning-Plattform für Dermatochirurgie].
000181943 260__ $$a[Berlin]$$bSpringer Medizin Verlag GmbH$$c2022
000181943 3367_ $$2DRIVER$$aarticle
000181943 3367_ $$2DataCite$$aOutput Types/Journal article
000181943 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1669814187_4797
000181943 3367_ $$2BibTeX$$aARTICLE
000181943 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181943 3367_ $$00$$2EndNote$$aJournal Article
000181943 500__ $$aDie Dermatologie (Dermatologie) = 2731-7013  / #LA:A190# / 2022 Dec;73(12):943-951
000181943 520__ $$aDermatosurgical (DS) teaching is based on a combination of reading/understanding textbooks and applying surgical procedures (± supervision). Most textbooks are primarily text-centered. The text is visually supported by photos/sketches (S) and possibly videos (V). A learning goal of this teaching should be that the learner is confident to perform a procedure independently.We have developed an online-based platform, the FlapFinder (FF; www.skin-surgery.org ), which teaches the user DS in the facial region primarily in the form of S + V. These are supported by a short text (T) and bonus material (B). B contains personal recommendations from the FF authors. A SurveyMonkey® (Survey Monkey, San Mateo, CA, USA) analysis should clarify how this is assessed by the user.In all, 62 participants completed the questionnaire in full. This was a heterogeneous group (27 dermatologists vs. 35 non-dermatologists; 32 × clinic vs. 30 × non-clinic) with different prior experience. The majority of users found that the combination of T + S + V helped them to understand (55/62; 88.7%), remember (53/62, 85.5%), and perform the procedures independently (43/62; 69.3%). While S + V were most frequently used (22/62; 35.5% and 27/62; 43.6%), users reported having benefited most from this (20/62; 32.3% and 24/62; 38.7%), T + B were used less (0/62, 0.0% and 2/62; 3.2%). Nevertheless, the majority would not want to do without either S, V, T, or B (49/62; 79%).The combination of S + V + T + B is rated positively by DS learners. S + V are rated as particularly helpful. Future studies must clarify whether the learning objective of the concrete practical performance of DS is changed by e‑media.
000181943 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000181943 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181943 650_7 $$2Other$$aClosure techniques
000181943 650_7 $$2Other$$aDermato-oncology
000181943 650_7 $$2Other$$aMultimedia learning
000181943 650_7 $$2Other$$aReconstructive surgery
000181943 650_7 $$2Other$$aTumor excision
000181943 7001_ $$0P:(DE-He78)72fa0d570de4683b3eae28f335924d81$$aHübers, Corinne$$b1$$udkfz
000181943 7001_ $$aBenecke, Johannes$$b2
000181943 7001_ $$aReiners-Koch, Philipp-Sebastian$$b3
000181943 7001_ $$0P:(DE-He78)28b708d8e88fbb959e31ff6770aaa6c7$$aFelcht, Moritz$$b4$$eLast author$$udkfz
000181943 773__ $$0PERI:(DE-600)3122900-1$$a10.1007/s00105-022-05054-w$$n12$$p943-951$$tDie Dermatologie$$v73$$x2731-7013$$y2022
000181943 909CO $$ooai:inrepo02.dkfz.de:181943$$pVDB
000181943 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)72fa0d570de4683b3eae28f335924d81$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000181943 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)28b708d8e88fbb959e31ff6770aaa6c7$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000181943 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000181943 9141_ $$y2022
000181943 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000181943 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000181943 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000181943 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-18
000181943 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHAUTARZT : 2021$$d2022-11-18
000181943 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000181943 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-18
000181943 9202_ $$0I:(DE-He78)A190-20160331$$kA190$$lA190 Vaskuläre Onkologie und Metastasierung$$x0
000181943 9201_ $$0I:(DE-He78)A190-20160331$$kA190$$lA190 Vaskuläre Onkologie und Metastasierung$$x0
000181943 980__ $$ajournal
000181943 980__ $$aVDB
000181943 980__ $$aI:(DE-He78)A190-20160331
000181943 980__ $$aUNRESTRICTED